nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Lung neoplasm malignant—Topotecan—cervical cancer	0.0439	0.114	CcSEcCtD
Pramipexole—Intestinal obstruction—Topotecan—cervical cancer	0.0129	0.0337	CcSEcCtD
Pramipexole—Neuralgia—Topotecan—cervical cancer	0.0127	0.033	CcSEcCtD
Pramipexole—Rash erythematous—Topotecan—cervical cancer	0.0115	0.03	CcSEcCtD
Pramipexole—Dysmenorrhoea—Topotecan—cervical cancer	0.00969	0.0252	CcSEcCtD
Pramipexole—SLC22A2—renal system—cervical cancer	0.0095	0.054	CbGeAlD
Pramipexole—Bone pain—Topotecan—cervical cancer	0.0092	0.0239	CcSEcCtD
Pramipexole—Respiratory failure—Topotecan—cervical cancer	0.00897	0.0234	CcSEcCtD
Pramipexole—DRD5—female reproductive system—cervical cancer	0.00889	0.0505	CbGeAlD
Pramipexole—Pulmonary embolism—Topotecan—cervical cancer	0.00881	0.0229	CcSEcCtD
Pramipexole—Colitis—Topotecan—cervical cancer	0.00846	0.022	CcSEcCtD
Pramipexole—Neuropathy—Topotecan—cervical cancer	0.00827	0.0215	CcSEcCtD
Pramipexole—DRD5—female gonad—cervical cancer	0.00809	0.046	CbGeAlD
Pramipexole—Rash maculo-papular—Topotecan—cervical cancer	0.00801	0.0209	CcSEcCtD
Pramipexole—Neoplasm—Topotecan—cervical cancer	0.00796	0.0207	CcSEcCtD
Pramipexole—Sepsis—Topotecan—cervical cancer	0.00764	0.0199	CcSEcCtD
Pramipexole—Ear pain—Topotecan—cervical cancer	0.0075	0.0195	CcSEcCtD
Pramipexole—SLC22A1—renal system—cervical cancer	0.00671	0.0382	CbGeAlD
Pramipexole—Dermatitis bullous—Topotecan—cervical cancer	0.00669	0.0174	CcSEcCtD
Pramipexole—HTR2B—uterine cervix—cervical cancer	0.00661	0.0376	CbGeAlD
Pramipexole—Lethargy—Topotecan—cervical cancer	0.00653	0.017	CcSEcCtD
Pramipexole—HTR2B—decidua—cervical cancer	0.0063	0.0358	CbGeAlD
Pramipexole—Cardiac arrest—Topotecan—cervical cancer	0.00608	0.0158	CcSEcCtD
Pramipexole—HTR2B—endometrium—cervical cancer	0.00598	0.034	CbGeAlD
Pramipexole—Cramp muscle—Topotecan—cervical cancer	0.00576	0.015	CcSEcCtD
Pramipexole—HTR1A—renal system—cervical cancer	0.00554	0.0315	CbGeAlD
Pramipexole—HTR2B—uterus—cervical cancer	0.00551	0.0313	CbGeAlD
Pramipexole—HTR1B—female reproductive system—cervical cancer	0.0055	0.0313	CbGeAlD
Pramipexole—HTR1D—female reproductive system—cervical cancer	0.00533	0.0303	CbGeAlD
Pramipexole—HTR2C—female reproductive system—cervical cancer	0.00527	0.03	CbGeAlD
Pramipexole—ADRA2C—uterine cervix—cervical cancer	0.0052	0.0296	CbGeAlD
Pramipexole—Weight increased—Topotecan—cervical cancer	0.00503	0.0131	CcSEcCtD
Pramipexole—ADRA2C—decidua—cervical cancer	0.00496	0.0282	CbGeAlD
Pramipexole—Pneumonia—Topotecan—cervical cancer	0.00496	0.0129	CcSEcCtD
Pramipexole—HTR2B—female reproductive system—cervical cancer	0.00495	0.0282	CbGeAlD
Pramipexole—Infestation—Topotecan—cervical cancer	0.00493	0.0128	CcSEcCtD
Pramipexole—Infestation NOS—Topotecan—cervical cancer	0.00493	0.0128	CcSEcCtD
Pramipexole—ADRA2C—renal system—cervical cancer	0.00487	0.0277	CbGeAlD
Pramipexole—SLC22A1—vagina—cervical cancer	0.00486	0.0276	CbGeAlD
Pramipexole—Neuropathy peripheral—Topotecan—cervical cancer	0.00483	0.0126	CcSEcCtD
Pramipexole—Sweating—Topotecan—cervical cancer	0.00472	0.0123	CcSEcCtD
Pramipexole—ADRA2C—endometrium—cervical cancer	0.00471	0.0268	CbGeAlD
Pramipexole—Hepatobiliary disease—Topotecan—cervical cancer	0.00466	0.0121	CcSEcCtD
Pramipexole—Epistaxis—Topotecan—cervical cancer	0.00465	0.0121	CcSEcCtD
Pramipexole—ADRA2C—mammalian vulva—cervical cancer	0.00455	0.0259	CbGeAlD
Pramipexole—HTR2B—vagina—cervical cancer	0.00448	0.0255	CbGeAlD
Pramipexole—Rhinitis—Topotecan—cervical cancer	0.00444	0.0115	CcSEcCtD
Pramipexole—Hypoaesthesia—Topotecan—cervical cancer	0.0044	0.0115	CcSEcCtD
Pramipexole—Pharyngitis—Topotecan—cervical cancer	0.00439	0.0114	CcSEcCtD
Pramipexole—ADRA2C—uterus—cervical cancer	0.00434	0.0247	CbGeAlD
Pramipexole—ADRA2A—uterine cervix—cervical cancer	0.00415	0.0236	CbGeAlD
Pramipexole—Angiopathy—Topotecan—cervical cancer	0.00401	0.0105	CcSEcCtD
Pramipexole—Immune system disorder—Topotecan—cervical cancer	0.004	0.0104	CcSEcCtD
Pramipexole—Mediastinal disorder—Topotecan—cervical cancer	0.00399	0.0104	CcSEcCtD
Pramipexole—Chills—Topotecan—cervical cancer	0.00397	0.0103	CcSEcCtD
Pramipexole—ADRA2A—decidua—cervical cancer	0.00396	0.0225	CbGeAlD
Pramipexole—Alopecia—Topotecan—cervical cancer	0.00391	0.0102	CcSEcCtD
Pramipexole—Malnutrition—Topotecan—cervical cancer	0.00385	0.01	CcSEcCtD
Pramipexole—ADRA2A—endometrium—cervical cancer	0.00376	0.0214	CbGeAlD
Pramipexole—Back pain—Topotecan—cervical cancer	0.00373	0.0097	CcSEcCtD
Pramipexole—Muscle spasms—Topotecan—cervical cancer	0.0037	0.00964	CcSEcCtD
Pramipexole—ADRA2A—mammalian vulva—cervical cancer	0.00363	0.0207	CbGeAlD
Pramipexole—Ill-defined disorder—Topotecan—cervical cancer	0.00357	0.0093	CcSEcCtD
Pramipexole—HTR2A—epithelium—cervical cancer	0.00356	0.0203	CbGeAlD
Pramipexole—Anaemia—Topotecan—cervical cancer	0.00356	0.00927	CcSEcCtD
Pramipexole—ADRA2C—female gonad—cervical cancer	0.00355	0.0202	CbGeAlD
Pramipexole—ADRA2C—vagina—cervical cancer	0.00353	0.0201	CbGeAlD
Pramipexole—Malaise—Topotecan—cervical cancer	0.00347	0.00904	CcSEcCtD
Pramipexole—ADRA2A—uterus—cervical cancer	0.00346	0.0197	CbGeAlD
Pramipexole—Leukopenia—Topotecan—cervical cancer	0.00345	0.00898	CcSEcCtD
Pramipexole—Cough—Topotecan—cervical cancer	0.00336	0.00875	CcSEcCtD
Pramipexole—HTR2A—renal system—cervical cancer	0.0033	0.0188	CbGeAlD
Pramipexole—Arthralgia—Topotecan—cervical cancer	0.00328	0.00854	CcSEcCtD
Pramipexole—Myalgia—Topotecan—cervical cancer	0.00328	0.00854	CcSEcCtD
Pramipexole—Chest pain—Topotecan—cervical cancer	0.00328	0.00854	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00326	0.00848	CcSEcCtD
Pramipexole—Discomfort—Topotecan—cervical cancer	0.00324	0.00844	CcSEcCtD
Pramipexole—Infection—Topotecan—cervical cancer	0.00312	0.00813	CcSEcCtD
Pramipexole—ADRA2A—female reproductive system—cervical cancer	0.00311	0.0177	CbGeAlD
Pramipexole—Nervous system disorder—Topotecan—cervical cancer	0.00308	0.00803	CcSEcCtD
Pramipexole—Thrombocytopenia—Topotecan—cervical cancer	0.00308	0.00801	CcSEcCtD
Pramipexole—Skin disorder—Topotecan—cervical cancer	0.00305	0.00795	CcSEcCtD
Pramipexole—Hyperhidrosis—Topotecan—cervical cancer	0.00304	0.00791	CcSEcCtD
Pramipexole—Anorexia—Topotecan—cervical cancer	0.003	0.0078	CcSEcCtD
Pramipexole—HTR2B—lymph node—cervical cancer	0.0029	0.0165	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00286	0.00746	CcSEcCtD
Pramipexole—ADRA2A—female gonad—cervical cancer	0.00283	0.0161	CbGeAlD
Pramipexole—Paraesthesia—Topotecan—cervical cancer	0.00282	0.00735	CcSEcCtD
Pramipexole—ADRA2A—vagina—cervical cancer	0.00281	0.016	CbGeAlD
Pramipexole—Dyspnoea—Topotecan—cervical cancer	0.0028	0.0073	CcSEcCtD
Pramipexole—Dyspepsia—Topotecan—cervical cancer	0.00277	0.0072	CcSEcCtD
Pramipexole—Decreased appetite—Topotecan—cervical cancer	0.00273	0.00711	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Topotecan—cervical cancer	0.00271	0.00707	CcSEcCtD
Pramipexole—Fatigue—Topotecan—cervical cancer	0.00271	0.00706	CcSEcCtD
Pramipexole—Pain—Topotecan—cervical cancer	0.00269	0.007	CcSEcCtD
Pramipexole—Constipation—Topotecan—cervical cancer	0.00269	0.007	CcSEcCtD
Pramipexole—HTR2A—female reproductive system—cervical cancer	0.00265	0.015	CbGeAlD
Pramipexole—Feeling abnormal—Topotecan—cervical cancer	0.00259	0.00674	CcSEcCtD
Pramipexole—Gastrointestinal pain—Topotecan—cervical cancer	0.00257	0.00669	CcSEcCtD
Pramipexole—Urticaria—Topotecan—cervical cancer	0.0025	0.0065	CcSEcCtD
Pramipexole—Body temperature increased—Topotecan—cervical cancer	0.00248	0.00647	CcSEcCtD
Pramipexole—Abdominal pain—Topotecan—cervical cancer	0.00248	0.00647	CcSEcCtD
Pramipexole—HTR2A—vagina—cervical cancer	0.00239	0.0136	CbGeAlD
Pramipexole—Hypersensitivity—Topotecan—cervical cancer	0.00232	0.00603	CcSEcCtD
Pramipexole—ADRA2C—lymph node—cervical cancer	0.00228	0.013	CbGeAlD
Pramipexole—Asthenia—Topotecan—cervical cancer	0.00226	0.00587	CcSEcCtD
Pramipexole—Pruritus—Topotecan—cervical cancer	0.00222	0.00579	CcSEcCtD
Pramipexole—Diarrhoea—Topotecan—cervical cancer	0.00215	0.0056	CcSEcCtD
Pramipexole—Dizziness—Topotecan—cervical cancer	0.00208	0.00541	CcSEcCtD
Pramipexole—Vomiting—Topotecan—cervical cancer	0.002	0.0052	CcSEcCtD
Pramipexole—Rash—Topotecan—cervical cancer	0.00198	0.00516	CcSEcCtD
Pramipexole—Dermatitis—Topotecan—cervical cancer	0.00198	0.00516	CcSEcCtD
Pramipexole—Headache—Topotecan—cervical cancer	0.00197	0.00513	CcSEcCtD
Pramipexole—Nausea—Topotecan—cervical cancer	0.00187	0.00486	CcSEcCtD
Pramipexole—ADRA2A—lymph node—cervical cancer	0.00182	0.0104	CbGeAlD
Pramipexole—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.000494	0.00112	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKAP13—cervical cancer	0.000486	0.0011	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.000485	0.0011	CbGpPWpGaD
Pramipexole—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000483	0.0011	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000478	0.00109	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—WNT2—cervical cancer	0.000453	0.00103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.000449	0.00102	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.000449	0.00102	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.000448	0.00102	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—WNT5A—cervical cancer	0.000448	0.00102	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—WNT2—cervical cancer	0.000443	0.00101	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.000441	0.001	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—WNT2—cervical cancer	0.000436	0.000991	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000434	0.000987	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000434	0.000985	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000433	0.000985	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000433	0.000983	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000431	0.000979	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.00043	0.000978	CbGpPWpGaD
Pramipexole—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000422	0.000959	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	0.000419	0.000953	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	0.000419	0.000951	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.000417	0.000946	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000398	0.000903	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000395	0.000896	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—WNT2—cervical cancer	0.000393	0.000892	CbGpPWpGaD
Pramipexole—DRD4—Circadian rythm related genes—TP53—cervical cancer	0.000392	0.00089	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKAP13—cervical cancer	0.000389	0.000884	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—WNT2—cervical cancer	0.000388	0.000881	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.000383	0.00087	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.00038	0.000864	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.00038	0.000863	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CA9—cervical cancer	0.00038	0.000862	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000374	0.000851	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000374	0.000849	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CA9—cervical cancer	0.000369	0.000839	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.000366	0.000831	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CA9—cervical cancer	0.000354	0.000804	CbGpPWpGaD
Pramipexole—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000353	0.000802	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.00035	0.000795	CbGpPWpGaD
Pramipexole—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.000348	0.000791	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000345	0.000784	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000343	0.00078	CbGpPWpGaD
Pramipexole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000341	0.000774	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000341	0.000774	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.00034	0.000773	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.00034	0.000773	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000338	0.000767	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000336	0.000763	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.000336	0.000763	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.000331	0.000751	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000327	0.000743	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000316	0.000717	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NOTCH2—cervical cancer	0.000314	0.000714	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000307	0.000698	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CA9—cervical cancer	0.0003	0.000681	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000298	0.000676	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000297	0.000674	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000297	0.000674	CbGpPWpGaD
Pramipexole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000296	0.000672	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000295	0.00067	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000294	0.000667	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000292	0.000663	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000287	0.000652	CbGpPWpGaD
Pramipexole—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000266	0.000605	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000265	0.000603	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000265	0.000602	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.00026	0.000592	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HES1—cervical cancer	0.000258	0.000586	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000256	0.000582	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000256	0.000582	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000255	0.000579	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000248	0.000563	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000241	0.000547	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000236	0.000536	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000233	0.00053	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000232	0.000527	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TERT—cervical cancer	0.000226	0.000513	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000225	0.000511	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000222	0.000503	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000221	0.000502	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000209	0.000475	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000207	0.000471	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000206	0.000468	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000201	0.000457	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000197	0.000449	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000195	0.000442	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000193	0.000439	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HES1—cervical cancer	0.00019	0.000432	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000186	0.000423	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000182	0.000413	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00018	0.000408	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000179	0.000406	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000174	0.000395	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000173	0.000394	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000173	0.000393	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HES1—cervical cancer	0.000171	0.000389	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000169	0.000385	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HES1—cervical cancer	0.000169	0.000384	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TERT—cervical cancer	0.000167	0.000379	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000159	0.000362	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000159	0.000361	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000158	0.000358	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000156	0.000353	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000155	0.000353	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—MTHFR—cervical cancer	0.000154	0.00035	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000153	0.000348	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000153	0.000347	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—cervical cancer	0.00015	0.000341	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TERT—cervical cancer	0.00015	0.000341	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—MTHFR—cervical cancer	0.00015	0.00034	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000149	0.000339	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TERT—cervical cancer	0.000148	0.000337	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000147	0.000335	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000147	0.000333	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000146	0.000332	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000146	0.000332	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000146	0.000331	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000144	0.000326	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—MTHFR—cervical cancer	0.000144	0.000326	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000143	0.000324	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000141	0.000321	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—cervical cancer	0.00014	0.000319	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000138	0.000313	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000137	0.000312	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000136	0.000309	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000134	0.000305	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000134	0.000304	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000133	0.000302	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—cervical cancer	0.00013	0.000296	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HES1—cervical cancer	0.000129	0.000294	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000129	0.000294	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000129	0.000294	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000129	0.000293	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000128	0.000292	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000128	0.000291	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000128	0.00029	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000127	0.000289	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000125	0.000284	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000123	0.000279	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000122	0.000278	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000122	0.000276	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000118	0.000269	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000118	0.000268	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000116	0.000263	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000115	0.000262	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000115	0.000262	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000115	0.00026	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—cervical cancer	0.000114	0.000259	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000114	0.000258	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TERT—cervical cancer	0.000113	0.000257	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000113	0.000256	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000112	0.000254	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000112	0.000253	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000111	0.000253	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000111	0.000251	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MTOR—cervical cancer	0.000109	0.000249	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000108	0.000245	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000108	0.000244	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000104	0.000236	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.000103	0.000233	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.000103	0.000233	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000103	0.000233	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—cervical cancer	0.000102	0.000233	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000233	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000101	0.000231	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—cervical cancer	0.000101	0.000229	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—cervical cancer	9.91e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	9.91e-05	0.000225	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—cervical cancer	9.9e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—cervical cancer	9.86e-05	0.000224	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOTCH1—cervical cancer	9.76e-05	0.000222	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	9.7e-05	0.00022	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MTOR—cervical cancer	9.69e-05	0.00022	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	9.61e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	9.59e-05	0.000218	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MTOR—cervical cancer	9.56e-05	0.000217	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CTNNB1—cervical cancer	9.54e-05	0.000217	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—cervical cancer	9.45e-05	0.000215	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	9.31e-05	0.000212	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	9.11e-05	0.000207	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—cervical cancer	8.91e-05	0.000203	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—cervical cancer	8.79e-05	0.0002	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	8.74e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—cervical cancer	8.7e-05	0.000198	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—STAT3—cervical cancer	8.63e-05	0.000196	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MTOR—cervical cancer	8.63e-05	0.000196	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—cervical cancer	8.6e-05	0.000195	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CTNNB1—cervical cancer	8.59e-05	0.000195	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—cervical cancer	8.56e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CTNNB1—cervical cancer	8.48e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—STAT3—cervical cancer	8.45e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MTOR—cervical cancer	8.33e-05	0.000189	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—STAT3—cervical cancer	8.32e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MTOR—cervical cancer	8.29e-05	0.000188	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MTOR—cervical cancer	8.06e-05	0.000183	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—STAT3—cervical cancer	7.94e-05	0.00018	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—cervical cancer	7.94e-05	0.00018	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—cervical cancer	7.85e-05	0.000178	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	7.79e-05	0.000177	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—cervical cancer	7.68e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—cervical cancer	7.66e-05	0.000174	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	7.65e-05	0.000174	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—cervical cancer	7.63e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—cervical cancer	7.56e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—STAT3—cervical cancer	7.49e-05	0.00017	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—cervical cancer	7.42e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—STAT3—cervical cancer	7.39e-05	0.000168	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	7.39e-05	0.000168	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	7.35e-05	0.000167	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MTOR—cervical cancer	7.32e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—cervical cancer	7.22e-05	0.000164	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MTOR—cervical cancer	7.2e-05	0.000164	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	7.15e-05	0.000162	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—cervical cancer	6.81e-05	0.000155	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—cervical cancer	6.73e-05	0.000153	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—cervical cancer	6.72e-05	0.000153	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—STAT3—cervical cancer	6.67e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—cervical cancer	6.62e-05	0.00015	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—cervical cancer	6.59e-05	0.00015	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MTOR—cervical cancer	6.55e-05	0.000149	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CTNNB1—cervical cancer	6.49e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—cervical cancer	6.45e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—STAT3—cervical cancer	6.44e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—STAT3—cervical cancer	6.41e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	6.38e-05	0.000145	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—cervical cancer	6.35e-05	0.000144	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—STAT3—cervical cancer	6.23e-05	0.000142	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—cervical cancer	6.06e-05	0.000138	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—cervical cancer	6.06e-05	0.000138	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—cervical cancer	6.02e-05	0.000137	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—cervical cancer	5.85e-05	0.000133	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—cervical cancer	5.82e-05	0.000132	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	5.81e-05	0.000132	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—cervical cancer	5.72e-05	0.00013	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—cervical cancer	5.66e-05	0.000129	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—STAT3—cervical cancer	5.65e-05	0.000128	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—cervical cancer	5.64e-05	0.000128	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—STAT3—cervical cancer	5.56e-05	0.000126	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—cervical cancer	5.14e-05	0.000117	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—cervical cancer	5.09e-05	0.000116	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT3—cervical cancer	5.06e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—cervical cancer	5.06e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—cervical cancer	4.91e-05	0.000112	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—cervical cancer	4.89e-05	0.000111	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—cervical cancer	4.76e-05	0.000108	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—cervical cancer	4.6e-05	0.000105	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—cervical cancer	4.31e-05	9.8e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—cervical cancer	4.25e-05	9.65e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—cervical cancer	3.86e-05	8.78e-05	CbGpPWpGaD
